Page last updated: 2024-11-05

4-aminobenzaldehyde

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

4-aminobenzaldehyde: a yellow colorimetric indicator for detecting fluoride; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID11158
CHEMBL ID1885510
CHEBI ID190128
SCHEMBL ID214899
MeSH IDM0577762

Synonyms (54)

Synonym
4-amino-benzaldehyde
benzaldehyde, 4-amino-
p-aminobenzaldehyde
benzaldehyde, p-amino-
4-aminobenzaldehyde
wln: zr dvh
nsc45163
556-18-3
nsc-45163
nsc60117
nsc-60117
28107-09-7
p-formylaniline
brn 1362885
nsc 45163
4-formylaniline
einecs 209-115-2
vatywcrqdjirai-uhfffaoysa-
inchi=1/c7h7no/c8-7-3-1-6(5-9)2-4-7/h1-5h,8h2
A0260 ,
CHEBI:190128
AKOS004902086
NCGC00184183-03
NCGC00184183-02
NCGC00184183-01
A830723
4-azanylbenzaldehyde
BBL013016
STL163885
unii-74q1671ts1
74q1671ts1 ,
4-14-00-00048 (beilstein handbook reference)
ccris 8885
FT-0601039
SCHEMBL214899
DTXSID3060299
p-amino-benzaldehyde
para-aminobenzaldehyde
VATYWCRQDJIRAI-UHFFFAOYSA-N
CHEMBL1885510
J-514422
4-aminobenzaldehyde, aldrichcpr
mfcd00038137
GS-3084
p-aminobenzaldehyd
ccris-8885
aminobenzaldehyde, p-
SY003470
CS-0112994
F8883-5867
Q21099246
A936241
HY-W076836
EN300-85865
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
benzaldehydesAny arenecarbaldehyde that consists of a formyl substituted benzene ring and its substituted derivatives thereof.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (1)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Smad3Homo sapiens (human)Potency28.18380.00527.809829.0929AID588855
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID1337095Inhibition of human MPO2017ACS medicinal chemistry letters, Feb-09, Volume: 8, Issue:2
From Dynamic Combinatorial Chemistry to
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (100.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 55.50

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index55.50 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.51 (4.65)
Search Engine Demand Index83.21 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (55.50)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]